Pharma Lynx, LLC

pharmalynx.com

At Pharma Lynx, we emphasize long-term, value added relationships with a commitment to understand our customer’s business needs. By leveraging proven industry expertise, we concentrate on providing comprehensive Clinical Trials & Data Management Services to the pharmaceutical, biotechnology, generic drug, and medical device companies in the areas of Oncology, Central Nervous System (CNS), Infectious Disease & Vaccines therapeutic areas. Services Offered by Pharma Lynx: - Clinical Development Plan - Site selection - Clinical monitoring - Medical monitoring - Safety monitoring - Data Management/EDC - Biostatistics Analysis - What makes Pharma Lynx unique from other CROs? Data management is a core service of Pharma Lynx and a critical element of our customer value proposition. Pharma Lynx is headquartered out of Princeton, New Jersey, USA with an offshore office in Noida, India, and an exclusive partnership in Munich, Germany.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

WITH VEEVA ECONSENT, CELERION IS CHANGING THE CONSENT EXPERIENCE FOR CLINICS AND PATIENTS

Veeva Systems | October 07, 2021

news image

Veeva Systems (NYSE: VEEV ) announced that Celerion has launched Veeva eConsent , a MyVeeva for Patients solution, to provide electronic consent for its Phase I clinical trials obtain. With Veeva eConsent, Celerion is moving from manual and paper-based consent forms to a fully digital process. The company uses Veeva eConsent for several studies and has already given their consent to more than 200 test subjects. Covid-19 limited the time we cou...

Read More

Pharma Tech

ARISGLOBAL'S LIFESPHERE REGULATORY IDMP PRODUCT LEADER INVITED TO CHAIR AMERICAN NATIONAL STANDARDS INSTITUTE GLOBAL MPID PROJECT

ArisGlobal | August 23, 2022

news image

ArisGlobal, the leading provider of life sciences software that automates core drug development functions with its end-to-end technology platform LifeSphere®, today recognizes and applauds the accomplishments of their LifeSphere® Regulatory IDMP product leader, Robin Schilling, for her acceptance into American National Standards Institute (ANSI) and the nonprofit's specific ISO Health Informatics Technical Committee, Working Group 6, which helps develop standardizations for Pharmacy ...

Read More

COVECTRA ANNOUNCES VRS FOR PHARMACEUTICAL MANUFACTURERS TO ENHANCE DRUG SUPPLY CHAIN SECURITY

Covectra | June 22, 2020

news image

Covectra, a leader in track and trace solutions, today announced the Covectra Verification Router Service (VRS), a complete API solution enabling pharmaceutical brands to validate the status of a returned product to ascertain its resell ability and ensure regulatory compliance with the upcoming Drug Supply Chain and Security Act (DSCSA) saleable returns requirement. In November 2020, the FDA enforcement will begin as pharmaceutical distributors of regulated medicines will need to ...

Read More

Research

DISPERSOL TECHNOLOGIES ANNOUNCES COLLABORATION WITH AJAX THERAPEUTICS TO DEVELOP ENHANCED KINETISOL DRUG FORMULATIONS

DisperSol Technologies | December 18, 2021

news image

DisperSol Technologies LLC announced that it is has entered into a research collaboration with Ajax Therapeutics, Inc. to apply its KinetiSol technology to enhance the bioavailability of an Ajax drug candidate in development for the treatment of hematologic malignancies. “Ajax is taking an innovative approach to developing a pipeline of selectively targeted small molecules and we look forward to applying our proprietary KinetiSol technology to help enha...

Read More
news image

Business Insights

WITH VEEVA ECONSENT, CELERION IS CHANGING THE CONSENT EXPERIENCE FOR CLINICS AND PATIENTS

Veeva Systems | October 07, 2021

Veeva Systems (NYSE: VEEV ) announced that Celerion has launched Veeva eConsent , a MyVeeva for Patients solution, to provide electronic consent for its Phase I clinical trials obtain. With Veeva eConsent, Celerion is moving from manual and paper-based consent forms to a fully digital process. The company uses Veeva eConsent for several studies and has already given their consent to more than 200 test subjects. Covid-19 limited the time we cou...

Read More
news image

Pharma Tech

ARISGLOBAL'S LIFESPHERE REGULATORY IDMP PRODUCT LEADER INVITED TO CHAIR AMERICAN NATIONAL STANDARDS INSTITUTE GLOBAL MPID PROJECT

ArisGlobal | August 23, 2022

ArisGlobal, the leading provider of life sciences software that automates core drug development functions with its end-to-end technology platform LifeSphere®, today recognizes and applauds the accomplishments of their LifeSphere® Regulatory IDMP product leader, Robin Schilling, for her acceptance into American National Standards Institute (ANSI) and the nonprofit's specific ISO Health Informatics Technical Committee, Working Group 6, which helps develop standardizations for Pharmacy ...

Read More
news image

COVECTRA ANNOUNCES VRS FOR PHARMACEUTICAL MANUFACTURERS TO ENHANCE DRUG SUPPLY CHAIN SECURITY

Covectra | June 22, 2020

Covectra, a leader in track and trace solutions, today announced the Covectra Verification Router Service (VRS), a complete API solution enabling pharmaceutical brands to validate the status of a returned product to ascertain its resell ability and ensure regulatory compliance with the upcoming Drug Supply Chain and Security Act (DSCSA) saleable returns requirement. In November 2020, the FDA enforcement will begin as pharmaceutical distributors of regulated medicines will need to ...

Read More
news image

Research

DISPERSOL TECHNOLOGIES ANNOUNCES COLLABORATION WITH AJAX THERAPEUTICS TO DEVELOP ENHANCED KINETISOL DRUG FORMULATIONS

DisperSol Technologies | December 18, 2021

DisperSol Technologies LLC announced that it is has entered into a research collaboration with Ajax Therapeutics, Inc. to apply its KinetiSol technology to enhance the bioavailability of an Ajax drug candidate in development for the treatment of hematologic malignancies. “Ajax is taking an innovative approach to developing a pipeline of selectively targeted small molecules and we look forward to applying our proprietary KinetiSol technology to help enha...

Read More